Submit or Track your Manuscript LOG-IN

Could Angiotensin Converting Enzyme 2 Inhibitor (ACE2) be the First Line of Defence against SARS-CoV-2 Diseases Covid-19?

Could Angiotensin Converting Enzyme 2 Inhibitor (ACE2) be the First Line of Defence against SARS-CoV-2 Diseases Covid-19?

Daniel Kerr Baines 

The Lancaster University, Lancaster, United Kingdom

3edjdexndbnbwsenws 

ABSTRACT

 

To share on other social networks, click on P-share. What are these?

Hosts and Viruses

June

Vol. 7, Iss. 3, Pages 39-58

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe